Global In Vitro Diagnostics Market Outlook, 2021

Healthcare Global In Vitro Diagnostics Market Outlook, 2021

Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
20-Sep-2021
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K5C8-01-00-00-00
SKU
HC03451-NA-MT_25793
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03451-NA-MT_25793

Global In Vitro Diagnostics Market Outlook, 2021
Published on: 20-Sep-2021 | SKU: HC03451-NA-MT_25793

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of the In Vitro Diagnostics (IVD) industry has unfolded through the COVID-19 pandemic, as it continued to serve the healthcare domain and successfully reach a revenue of $85.91 billion in 2020. Clinical chemistry and immunoassays dominate the revenue share; molecular diagnostics and point-of-care-testing continue to grow at the highest rates; and tissue diagnostics and hemostasis will experience moderate growth followed by rest of the technology segments. The top-10 companies serving the IVD industry together accounted for 65.2% of the global revenue in 2020, while the top-20 companies together made up 78.8% of the global proceeds. The NA region, primarily with contributions from the US, leads the market, maintaining its stronghold on the IVD industry. APAC, primarily driven by Japan, China, and India, along with the other growing economies will experience the highest growth rate, while Europe will continue to grow at a slower pace. Overall, this research service offers insightful analysis in the form of overall forecast, region, and technology segment wise analysis, benchmarking of top participants, and key growth opportunities that will shape the industry.

Author: Amol Dilip Jadhav

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the In Vitro Diagnostics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

In Vitro Diagnostics Market Scope of Analysis

In Vitro Diagnostics Market Based on Workflow

In Vitro Diagnostics Market Segmentation Based on Technologies

In Vitro Diagnostics Market Definition Technology Segments

In Vitro Diagnostics Market Segmentation Based on Region

Key Competitors for In Vitro Diagnostics Market

Key Growth Metrics for In Vitro Diagnostics Market

In Vitro Diagnostics Market Growth Outlook Summary

Decentralized Testing to Drive Growth—In Vitro Diagnostics Market

Growth Drivers for In Vitro Diagnostics Market

Growth Restraints for In Vitro Diagnostics Market

Forecast Assumptions—In Vitro Diagnostics Market

Revenue Forecast—In Vitro Diagnostics Market

Revenue Forecast by Workflow—In Vitro Diagnostics Market

Revenue Forecast by Technology—In Vitro Diagnostics Market

Revenue Forecast by Region—In Vitro Diagnostics Market

Revenue Forecast Analysis—In Vitro Diagnostics Market

Revenue Forecast Analysis by Workflow Segments—In Vitro Diagnostics Market

Revenue Forecast Analysis by Selective Technology Segments—In Vitro Diagnostics Market

Revenue Forecast Analysis by Selective Technology Segments—In Vitro Diagnostics Market (continued)

Revenue Forecast Analysis by Region—In Vitro Diagnostics Market

Competitive Environment—In Vitro Diagnostics Market

Revenue Share—In Vitro Diagnostics Market

Revenue Share Analysis—In Vitro Diagnostics Market

Competitor Matrix—In Vitro Diagnostics Market

Competitor Matrix—In Vitro Diagnostics Market (continued)

Competitor Segment Ranking—In Vitro Diagnostics Market

Recent Notable Activities—In Vitro Diagnostics Market

Recent Notable Activities—In Vitro Diagnostics Market (continued)

Key Growth Metrics for Clinical Chemistry and Immunoassay

Revenue Forecast—Clinical Chemistry and Immunoassay

Forecast Analysis—Clinical Chemistry and Immunoassay

Key Growth Metrics for Molecular Diagnostics

Revenue Forecast—Molecular Diagnostics

Forecast Analysis—Molecular Diagnostics

Key Growth Metrics for Tissue Diagnostics

Revenue Forecast—Tissue Diagnostics

Forecast Analysis—Tissue Diagnostics

Key Growth Metrics for Point-of-Care-Testing

Revenue Forecast—Point-of-Care-Testing

Forecast Analysis—Point-of-Care-Testing

Key Growth Metrics for In Vitro Diagnostics Market—North America

Revenue Forecast for In Vitro Diagnostics Market—North America

Forecast Analysis by Technology for In Vitro Diagnostics Market—North America

Key Growth Metrics for In Vitro Diagnostics Market—Europe

Revenue Forecast for In Vitro Diagnostics Market—Europe

Forecast Analysis by Technology for In Vitro Diagnostics Market—Europe

Key Growth Metrics for In Vitro Diagnostics Market—APAC

Revenue Forecast for In Vitro Diagnostics Market—APAC

Forecast Analysis by Technology for In Vitro Diagnostics Market—APAC

Growth Opportunity 1: POCT Instruments for Diagnosis of Respiratory Infections

Growth Opportunity 1: POCT Instruments for Diagnosis of Respiratory Infections (continued)

Growth Opportunity 2: Direct-to-Consumer (DTC) Testing Services to Address Personalized Genetic Diagnostics

Growth Opportunity 2: Direct-to-Consumer (DTC) Testing Services to Address Personalized Genetic Diagnostics (continued)

Growth Opportunity 3: Digital Pathology with Artificial Intelligence Driving the Path to Precision Oncology

Growth Opportunity 3: Digital Pathology with Artificial Intelligence Driving the Path to Precision Oncology (continued)

Growth Opportunity 4: Smart Labs and Total Laboratory Automation for Shorter Testing Turnaround Time

Growth Opportunity 4: Smart Labs and Total Laboratory Automation for Shorter Testing Turnaround Time (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of the In Vitro Diagnostics (IVD) industry has unfolded through the COVID-19 pandemic, as it continued to serve the healthcare domain and successfully reach a revenue of $85.91 billion in 2020. Clinical chemistry and immunoassays dominate the revenue share; molecular diagnostics and point-of-care-testing continue to grow at the highest rates; and tissue diagnostics and hemostasis will experience moderate growth followed by rest of the technology segments. The top-10 companies serving the IVD industry together accounted for 65.2% of the global revenue in 2020, while the top-20 companies together made up 78.8% of the global proceeds. The NA region, primarily with contributions from the US, leads the market, maintaining its stronghold on the IVD industry. APAC, primarily driven by Japan, China, and India, along with the other growing economies will experience the highest growth rate, while Europe will continue to grow at a slower pace. Overall, this research service offers insightful analysis in the form of overall forecast, region, and technology segment wise analysis, benchmarking of top participants, and key growth opportunities that will shape the industry. Author: Amol Dilip Jadhav
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Amol Dilip Jadhav
Industries Healthcare
WIP Number K5C8-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9562-B1,9573-B1,99C6-B1,9627-B1